The detection of ADAMTS13 deficiency remains essential for identifying thrombotic microangiopathies that produce life-threatening blood clots through impaired VWF cleavage [1,13,14]. This evidence concerns the gene ADAMTS13 and Genetic thrombotic microangiopathy.